| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:2000467 | BP | positive regulation of glycogen (starch) synthase activity | Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity. |
IGF2, ADIPOQ, EPM2AIP1 |
GO:2000473 | BP | positive regulation of hematopoietic stem cell migration | Any process that activates or increases the frequency, rate or extent of hematopoietic stem cell migration. |
PTPRC |
GO:2000478 | BP | positive regulation of metanephric glomerular visceral epithelial cell development | Any process that activates or increases the frequency, rate or extent of metanephric glomerular visceral epithelial cell development. |
ADIPOQ |
GO:2000479 | BP | regulation of cAMP-dependent protein kinase activity | Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity. |
MST1, SESN2 |
GO:2000480 | BP | negative regulation of cAMP-dependent protein kinase activity | Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity. |
PRKAR1A, PRKAR2A, PRKAR2B, PKIA, PKIG |
GO:2000481 | BP | positive regulation of cAMP-dependent protein kinase activity | Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity. |
ATP2B4, ADIPOQ |
GO:2000482 | BP | regulation of interleukin-8 secretion | Any process that modulates the frequency, rate or extent of interleukin-8 secretion. |
CRP |
GO:2000483 | BP | negative regulation of interleukin-8 secretion | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-8 secretion. |
ANXA1, ANXA4, PTPN22 |
GO:2000484 | BP | positive regulation of interleukin-8 secretion | Any process that activates or increases the frequency, rate or extent of interleukin-8 secretion. |
CD58, F2R, WNT5A, F2RL1, HYAL2, CD244, PYCARD |
GO:2000486 | BP | negative regulation of glutamine transport | Any process that stops, prevents or reduces the frequency, rate or extent of glutamine transport. |
LEP |
GO:2000490 | BP | negative regulation of hepatic stellate cell activation | Any process that stops, prevents or reduces the frequency, rate or extent of hepatic stellate cell activation. |
GCLC, CYGB |
GO:2000491 | BP | positive regulation of hepatic stellate cell activation | Any process that activates or increases the frequency, rate or extent of hepatic stellate cell activation. |
PDGFRB, LEP, RPS6KA1 |
GO:2000502 | BP | negative regulation of natural killer cell chemotaxis | Any process that stops, prevents or reduces the frequency, rate or extent of natural killer cell chemotaxis. |
CCL2 |
GO:2000503 | BP | positive regulation of natural killer cell chemotaxis | Any process that activates or increases the frequency, rate or extent of natural killer cell chemotaxis. |
CXCL14, CCL3, CCL4, CCL5 |
GO:2000504 | BP | positive regulation of blood vessel remodeling | Any process that activates or increases the frequency, rate or extent of blood vessel remodeling. |
TMBIM1 |
GO:2000505 | BP | regulation of energy homeostasis | Any process that modulates the frequency, rate or extent of energy homeostasis. |
CD36, LEPR, PRKAA2, FOXO1, NR1D2, BMP8A, NR4A3, PASK |
GO:2000506 | BP | negative regulation of energy homeostasis | Any process that stops, prevents or reduces the frequency, rate or extent of energy homeostasis. |
FLCN, GHRL |
GO:2000507 | BP | positive regulation of energy homeostasis | Any process that activates or increases the frequency, rate or extent of energy homeostasis. |
TRPV4, PPARGC1A, GHRL |
GO:2000510 | BP | positive regulation of dendritic cell chemotaxis | Any process that activates or increases the frequency, rate or extent of dendritic cell chemotaxis. |
CALR, IL12A, C1QBP, GAS6 |
GO:2000516 | BP | positive regulation of CD4-positive, alpha-beta T cell activation | Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell activation. |
CD55 |
GO:2000521 | BP | negative regulation of immunological synapse formation | Any process that stops, prevents or reduces the frequency, rate or extent of immunological synapse formation. |
LGALS3 |
GO:2000533 | BP | negative regulation of renal albumin absorption | Any process that stops, prevents or reduces the frequency, rate or extent of renal albumin absorption. |
GAS6 |
GO:2000534 | BP | positive regulation of renal albumin absorption | Any process that activates or increases the frequency, rate or extent of renal albumin absorption. |
ADIPOQ |
GO:2000535 | BP | regulation of entry of bacterium into host cell | Any process that modulates the frequency, rate or extent of entry of bacterium into host cell. |
CXCL8, CAV1, EXOC2, FUCA2, EXOC7 |
GO:2000536 | BP | negative regulation of entry of bacterium into host cell | Any process that stops, prevents or reduces the frequency, rate or extent of entry of bacterium into host cell. |
ITGAV |
GO:2000541 | BP | positive regulation of protein geranylgeranylation | Any process that activates or increases the frequency, rate or extent of protein geranylgeranylation. |
MUSK |
GO:2000543 | BP | positive regulation of gastrulation | Any process that activates or increases the frequency, rate or extent of gastrulation. |
OTX2, RACK1, TENM4, OSR1 |
GO:2000544 | BP | regulation of endothelial cell chemotaxis to fibroblast growth factor | Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor. |
FGF2 |
GO:2000546 | BP | positive regulation of endothelial cell chemotaxis to fibroblast growth factor | Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor. |
FGF18, FGF2, FGFR1 |
GO:2000553 | BP | positive regulation of T-helper 2 cell cytokine production | Any process that activates or increases the frequency, rate or extent of T-helper 2 cell cytokine production. |
IL6 |
GO:2000560 | BP | positive regulation of CD24 biosynthetic process | Any process that activates or increases the frequency, rate or extent of CD24 biosynthetic process. |
PLCB1 |
GO:2000563 | BP | positive regulation of CD4-positive, alpha-beta T cell proliferation | Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation. |
CD55 |
GO:2000564 | BP | regulation of CD8-positive, alpha-beta T cell proliferation | Any process that modulates the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation. |
IRF1 |
GO:2000566 | BP | positive regulation of CD8-positive, alpha-beta T cell proliferation | Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation. |
HLA-E, CD244 |
GO:2000568 | BP | positive regulation of memory T cell activation | Any process that activates or increases the frequency, rate or extent of memory T cell activation. |
TNFSF4 |
GO:2000570 | BP | positive regulation of T-helper 2 cell activation | Any process that activates or increases the frequency, rate or extent of T-helper 2 cell activation. |
TNFSF4, PRKCQ |
GO:2000572 | BP | positive regulation of interleukin-4-dependent isotype switching to IgE isotypes | Any process that activates or increases the frequency, rate or extent of interleukin-4-dependent isotype switching to IgE isotypes. |
TNFSF4 |
GO:2000573 | BP | positive regulation of DNA biosynthetic process | Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process. |
PAK3, MYC, PDGFB, PDGFRB, HGF, PRKD2, RGCC, NOX4 |
GO:2000574 | BP | regulation of microtubule motor activity | Any process that modulates the frequency, rate or extent of microtubule motor activity. |
CCDC42B, NDEL1, NDE1 |
GO:2000584 | BP | negative regulation of platelet-derived growth factor receptor-alpha signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway. |
ADIPOQ |
GO:2000587 | BP | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway. |
PTPN2 |
GO:2000590 | BP | negative regulation of metanephric mesenchymal cell migration | Any process that stops, prevents or reduces the frequency, rate or extent of metanephric mesenchymal cell migration. |
ADIPOQ |
GO:2000591 | BP | positive regulation of metanephric mesenchymal cell migration | Any process that activates or increases the frequency, rate or extent of metanephric mesenchymal cell migration. |
PDGFB |
GO:2000594 | BP | positive regulation of metanephric DCT cell differentiation | Any process that activates or increases the frequency, rate or extent of metanephric DCT cell differentiation. |
PAX8 |
GO:2000601 | BP | positive regulation of Arp2/3 complex-mediated actin nucleation | Any process that activates or increases the frequency, rate or extent of Arp2/3 complex-mediated actin nucleation. |
WASL, CYFIP1, ABI2 |
GO:2000609 | BP | regulation of thyroid hormone generation | Any process that modulates the frequency, rate or extent of thyroid hormone generation. |
DUOXA1, DUOXA2 |
GO:2000611 | BP | positive regulation of thyroid hormone generation | Any process that activates or increases the frequency, rate or extent of thyroid hormone generation. |
PAX8 |
GO:2000612 | BP | regulation of thyroid-stimulating hormone secretion | Any process that modulates the frequency, rate or extent of thyroid-stimulating hormone secretion. |
PAX8 |
GO:2000615 | BP | regulation of histone H3-K9 acetylation | Any process that modulates the frequency, rate or extent of histone H3-K9 acetylation. |
CHEK1 |
GO:2000616 | BP | negative regulation of histone H3-K9 acetylation | Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 acetylation. |
ZNF451 |
GO:2000617 | BP | positive regulation of histone H3-K9 acetylation | Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation. |
BRCA1, SMAD4, NAP1L2 |
GO:2000620 | BP | positive regulation of histone H4-K16 acetylation | Any process that activates or increases the frequency, rate or extent of histone H4-K16 acetylation. |
BRCA1 |
GO:2000623 | BP | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. |
SECISBP2 |
GO:2000627 | BP | positive regulation of miRNA catabolic process | Any process that activates or increases the frequency, rate or extent of miRNA catabolic process. |
PNPT1 |
GO:2000628 | BP | regulation of miRNA metabolic process | Any process that modulates the frequency, rate or extent of miRNA metabolic process. |
KHSRP |
GO:2000630 | BP | positive regulation of miRNA metabolic process | Any process that activates or increases the frequency, rate or extent of miRNA metabolic process. |
NFKB1, RELA |
GO:2000632 | BP | negative regulation of pre-miRNA processing | Any process that stops, prevents or reduces the frequency, rate or extent of pre-microRNA processing. |
BCDIN3D |
GO:2000637 | BP | positive regulation of gene silencing by miRNA | Any process that activates or increases the frequency, rate or extent of gene silencing by miRNA. |
ZFP36, STAT3, FXR1, FMR1, PUM1, PUM2, AJUBA, LIMD1 |
GO:2000641 | BP | regulation of early endosome to late endosome transport | Any process that modulates the frequency, rate or extent of early endosome to late endosome transport. |
MAPK3, MAPK1, MAP2K2, MAP2K1 |
GO:2000642 | BP | negative regulation of early endosome to late endosome transport | Any process that stops, prevents or reduces the frequency, rate or extent of early endosome to late endosome transport. |
SNX3, SNX12 |
GO:2000643 | BP | positive regulation of early endosome to late endosome transport | Any process that activates or increases the frequency, rate or extent of early endosome to late endosome transport. |
EZR, RDX, DAB2, MTMR2, RAB21 |
GO:2000645 | BP | negative regulation of receptor catabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of receptor catabolic process. |
MTMR2 |
GO:2000647 | BP | negative regulation of stem cell proliferation | Any process that stops, prevents or reduces the frequency, rate or extent of stem cell proliferation. |
SNAI2, FBLN1 |
GO:2000648 | BP | positive regulation of stem cell proliferation | Any process that activates or increases the frequency, rate or extent of stem cell proliferation. |
KDM1A, PTPRC, EPCAM, HMGA2 |
GO:2000649 | BP | regulation of sodium ion transmembrane transporter activity | Any process that modulates the frequency, rate or extent of sodium ion transmembrane transporter activity. |
FXYD1, FXYD4, FGF12, YWHAH, RANGRF |
GO:2000650 | BP | negative regulation of sodium ion transmembrane transporter activity | Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transporter activity. |
CAMK2D, PCSK9, OSR1, NEDD4L |
GO:2000651 | BP | positive regulation of sodium ion transmembrane transporter activity | Any process that activates or increases the frequency, rate or extent of sodium ion transmembrane transporter activity. |
DMD, GLRX, ANK3, WNK3 |
GO:2000653 | BP | regulation of genetic imprinting | Any process that modulates the frequency, rate or extent of genetic imprinting. |
PIK3CA, TRIM28 |
GO:2000657 | BP | negative regulation of apolipoprotein binding | Any process that stops, prevents or reduces the frequency, rate or extent of apolipoprotein binding. |
MAPK3 |
GO:2000660 | BP | negative regulation of interleukin-1-mediated signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-1-mediated signaling pathway. |
IL6, IL1RN, IL1R2, ZNF675 |
GO:2000661 | BP | positive regulation of interleukin-1-mediated signaling pathway | Any process that activates or increases the frequency, rate or extent of interleukin-1-mediated signaling pathway. |
IL1R1 |
GO:2000663 | BP | negative regulation of interleukin-5 secretion | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-5 secretion. |
TNFRSF21 |
GO:2000664 | BP | positive regulation of interleukin-5 secretion | Any process that activates or increases the frequency, rate or extent of interleukin-5 secretion. |
IL17RB |
GO:2000666 | BP | negative regulation of interleukin-13 secretion | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-13 secretion. |
TNFRSF21 |
GO:2000667 | BP | positive regulation of interleukin-13 secretion | Any process that activates or increases the frequency, rate or extent of interleukin-13 secretion. |
PAEP, IL17RB |
GO:2000669 | BP | negative regulation of dendritic cell apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell apoptotic process. |
GAS6, LILRB1 |
GO:2000670 | BP | positive regulation of dendritic cell apoptotic process | Any process that activates or increases the frequency, rate or extent of dendritic cell apoptotic process. |
LYN |
GO:2000672 | BP | negative regulation of motor neuron apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron apoptotic process. |
ZPR1 |
GO:2000675 | BP | negative regulation of type B pancreatic cell apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of type B pancreatic cell apoptotic process. |
CAST, SRSF6, TCF7L2 |
GO:2000676 | BP | positive regulation of type B pancreatic cell apoptotic process | Any process that activates or increases the frequency, rate or extent of type B pancreatic cell apoptotic process. |
EIF2S1, IL6, HDAC1, CAPN10 |
GO:2000678 | BP | negative regulation of transcription regulatory region DNA binding | Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding. |
SRI, LHX2, PPARA, ZNF675, HEY1 |
GO:2000679 | BP | positive regulation of transcription regulatory region DNA binding | Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding. |
KLF4, TGFB1, IGF1, RB1, PARP1, HMGA2, TWIST1, TRIM6 |
GO:2000681 | BP | negative regulation of rubidium ion transport | Any process that stops, prevents or reduces the frequency, rate or extent of rubidium ion transport. |
CAB39 |
GO:2000682 | BP | positive regulation of rubidium ion transport | Any process that activates or increases the frequency, rate or extent of rubidium ion transport. |
WNK3 |
GO:2000685 | BP | positive regulation of cellular response to X-ray | Any process that activates or increases the frequency, rate or extent of cellular response to X-ray. |
HMGA2 |
GO:2000687 | BP | negative regulation of rubidium ion transmembrane transporter activity | Any process that stops, prevents or reduces the frequency, rate or extent of rubidium ion transmembrane transporter activity. |
CAB39 |
GO:2000688 | BP | positive regulation of rubidium ion transmembrane transporter activity | Any process that activates or increases the frequency, rate or extent of rubidium ion transmembrane transporter activity. |
WNK3 |
GO:2000691 | BP | negative regulation of cardiac muscle cell myoblast differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell myoblast differentiation. |
PRICKLE1 |
GO:2000696 | BP | regulation of epithelial cell differentiation involved in kidney development | Any process that modulates the frequency, rate or extent of epithelial cell differentiation involved in kidney development. |
PRKX |
GO:2000707 | BP | positive regulation of dense core granule biogenesis | Any process that activates or increases the frequency, rate or extent of dense core granule biogenesis. |
PRKCA |
GO:2000724 | BP | positive regulation of cardiac vascular smooth muscle cell differentiation | Any process that activates or increases the frequency, rate or extent of cardiac vascular smooth muscle cell differentiation. |
GPER1 |
GO:2000726 | BP | negative regulation of cardiac muscle cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell differentiation. |
DKK1, BMP2, SOX6 |
GO:2000727 | BP | positive regulation of cardiac muscle cell differentiation | Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation. |
GREM1, TGFB1, EFNB2, NRG1, MEF2C |
GO:2000736 | BP | regulation of stem cell differentiation | Any process that modulates the frequency, rate or extent of stem cell differentiation. |
TEAD2 |
GO:2000737 | BP | negative regulation of stem cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of stem cell differentiation. |
STAT3, NOTCH1, YAP1, ZFP36L2, JAG1, HES1, TRIM6 |
GO:2000738 | BP | positive regulation of stem cell differentiation | Any process that activates or increases the frequency, rate or extent of stem cell differentiation. |
GSK3B, PWP1 |
GO:2000739 | BP | regulation of mesenchymal stem cell differentiation | Any process that modulates the frequency, rate or extent of mesenchymal stem cell differentiation. |
PDGFRA |
GO:2000741 | BP | positive regulation of mesenchymal stem cell differentiation | Any process that activates or increases the frequency, rate or extent of mesenchymal stem cell differentiation. |
SOX6, SOX9, LTBP3 |
GO:2000744 | BP | positive regulation of anterior head development | Any process that activates or increases the frequency, rate or extent of anterior head development. |
SSBP3 |
GO:2000751 | BP | histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore | Any histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore. |
GSG2 |